Home > Boards > US Listed > Biotechs > Eloxx Pharmaceuticals Inc. (ELOX)

BILLIONAIRE DR. FROST INVESTS IN SEVION

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
rtraster Member Profile
 
Followed By 6
Posts 245
Boards Moderated 0
Alias Born 09/05/13
160x600 placeholder
Eloxx Pharmaceuticals Provides Enrollment Update for Ongoing Phase 2 Clinical Studies for Cystic Fibrosis GlobeNewswire Inc. - 7/6/2021 4:15:00 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/29/2021 9:14:38 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 6/16/2021 4:11:13 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/14/2021 4:02:07 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/27/2021 4:04:36 PM
Eloxx Pharmaceuticals gets $2.6M funding from Cystic Fibrosis Foundation Seeking Alpha - 5/27/2021 8:37:48 AM
Eloxx Pharmaceuticals Announces Funding Award from Cystic Fibrosis Foundation for Development of Ribosome Modulating Agents GlobeNewswire Inc. - 5/27/2021 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/26/2021 4:11:08 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 5/21/2021 4:06:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/20/2021 4:11:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/20/2021 4:11:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/20/2021 4:11:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/20/2021 4:11:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/20/2021 4:11:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/18/2021 5:48:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/18/2021 4:12:02 PM
Eloxx Pharmaceuticals, Inc. Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters’ O... GlobeNewswire Inc. - 5/18/2021 2:15:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/18/2021 8:18:06 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/17/2021 4:09:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/17/2021 7:04:34 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/17/2021 7:02:01 AM
Eloxx Pharmaceuticals prices 33M stock offering Seeking Alpha - 5/14/2021 7:29:35 AM
Eloxx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock GlobeNewswire Inc. - 5/14/2021 7:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/13/2021 4:39:49 PM
Eloxx Pharmaceuticals proposes stock offering Seeking Alpha - 5/13/2021 4:06:14 PM
rtraster   Thursday, 05/07/15 07:46:17 AM
Re: None
Post # of 782 
BILLIONAIRE DR. FROST INVESTS IN SEVION
Dr. Phillip Frost and Steve Rubin's OPKO HEALTH (OPK) are now investors in SVON with warrants at $1.50 per share! SEC Form 8K filed this morning.

"The net offering proceeds to the Company are expected to be approximately $1,512,226." (That's 10% of the current market cap of SVON by the way.)

"On May 6, 2015, OPKO Health, Inc. (“OPKO”), a multi-national biopharmaceutical and diagnostics company, agreed to participate in the Offering. Dr. Phillip Frost and Steve Rubin, who are members of the Company’s Board of Directors, are the Chief Executive Officer and Chairman and Executive Vice President-Administration of OPKO, respectively."

Read more:
http://www.sec.gov/Archives/edgar/data/1035354/000114420415028099/v409746_8k.htm

BOOM BOOM go Sevion Therapeutics, time to rock n roll, this stock will have a ton of action going forward now that Opko is involved. Check the chart of COCP (+200%) to see what Dr. Frost can do with small market cap stocks like SVON.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences